Recent data from the National Inpatient Sample (NIS) has revealed a concerning trend in the American West – a significant surge in hospital admissions for cardiomyopathy among methamphetamine users. This article will delve into the details of this study, analyzing the demographic and regional disparities highlighted by the researchers. According to the study, methamphetamine-related cardiomyopathy
Health
Space travel has long been a fascination for many, but recent studies have shed light on the potentially negative impacts it may have on the human body. A prospective study conducted on astronauts who participated in long-haul space flights revealed some startling findings regarding headaches experienced during their missions. The research, led by Willebrordus P.
The recent findings of an observational Swedish study on patients with attention-deficit/hyperactivity disorder (ADHD) have shed light on the potential association between starting medication and a lower risk of mortality, particularly from “unnatural” causes. These results have significant implications for the treatment of individuals with ADHD, as timely diagnosis and pharmacological intervention could potentially reduce
Amyotrophic lateral sclerosis (ALS) patients like Grace Armant face significant challenges when seeking coverage for the home ventilators they need to breathe. Insurance companies, including UnitedHealthcare, have been rejecting requests for these life-saving machines. This refusal puts patients at risk and forces them to deal with less effective devices initially to prove necessity. The demand
Richard Lowenthal, president and CEO of ARS Pharmaceuticals, shed light on the importance of testing intranasal epinephrine spray ARS-1 (also known as neffy) under extreme temperatures. The concerns raised by parents about leaving the EpiPen in the car and throwing it away due to fears of it getting hot highlighted the need for such testing.
The financial success of UnitedHealth Group (UHG) is staggering, with revenue reaching nearly $400 billion in 2023. This massive empire, fueled by profits of $22.4 billion, has raised concerns about the implications of its dominance in the healthcare industry. Through vertical integration and acquisitions like Optum, UHG has established a value-chain monopoly, controlling everything from